Red Abbey Venture Partners is a life sciences investment firm that was founded in 2004. Since that time, it has invested in 15 privately held and 9 publicly traded life sciences companies. Mission is to generate superior, risk-adjusted returns by investing in young companies that are developing the next generation of drugs and devices, as well as companies that are supporting these efforts with novel tools and products. Specifically, seeking to invest across the life sciences spectrum, which includes biotechnology, specialty pharmaceutical, medical device, diagnostics and research tools companies.
|Corridor Pharmaceuticals||6/10||Series A||$15M||8|
|Advanced BioHealing||2/07||Series C||$25.5M||5|
|Anacor Pharmaceutical||5/05||Series C||$25M||5|